State Street’s Augmedix, Inc. Common Stock AUGX Stock Holding History

State Street’s Portfolio AUGX Stock Details AUGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-150,413	Closed	-$353K	–	4369
2024 Q3	$353K	Buy	150,413 +12,200	+9%	+$24.6K	﹤0.01%	3662
2024 Q2	$122K	Buy	138,213 +10,600	+8%	+$21.9K	﹤0.01%	3950
2024 Q1	$522K	Sell	127,613 -3,500	-3%	-$15.7K	﹤0.01%	3634
2023 Q4	$767K	Buy	131,113 +39,700	+43%	+$209K	﹤0.01%	3535
2023 Q3	$471K	Buy	91,413 +32,282	+55%	+$151K	﹤0.01%	3676
2023 Q2	$284K	Buy	59,131 +35,431	+149%	+$123K	﹤0.01%	3897
2023 Q1	$41.2K	Hold	23,700	–	–	﹤0.01%	4550
2022 Q4	$37K	Hold	23,700	–	–	﹤0.01%	4623
2022 Q3	$34K	Hold	23,700	–	–	﹤0.01%	4740
2022 Q2	$43K	Buy	23,700 +12,300	+108%	+$28.5K	﹤0.01%	4752
2022 Q1	$34K	Buy	+11,400	New	+$30.9K	﹤0.01%	4854

State Street's AUGX Position: Q4 2024 in Review

State Street sold out of Augmedix, Inc. Common Stock (AUGX) in Q4 2024, closing a stake of 150,413 shares — an estimated $353K sold.

State Street first reported a position in AUGX in Q1 2022 and held it in 11 quarters. The position peaked at $767K in Q4 2023. 0 funds tracked by Wall St. Rank hold AUGX as of Q4 2024.

State Street reported no remaining Augmedix, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
State Street sold 150,413 Augmedix, Inc. Common Stock shares in Q4 2024, an estimated $353K.
State Street first reported a position in Augmedix, Inc. Common Stock in Q1 2022 and held it in 11 quarters.
State Street's Augmedix, Inc. Common Stock position peaked at $767K in Q4 2023.
0 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q4 2024.

Based on State Street's 13F filing for Q4 2024, filed 14 Feb 2025.